Clinical trials · Texas
Acute Treatment of Migraine clinical trials in Texas
We’re tracking 9 recruiting acute treatment of migraine studies with a site in Texas — including Phase 1, Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies in Texas
- NCT07674654RecruitingPhase 3
Long-term safety of elismetrep for acute migraine
This study tests the long-term safety of elismetrep (K-304), a medication for acute migraine attacks. It is for people who have already completed a previous elismetrep study and want to continue treatment under close medical supervision.
Austin, TexasAges 18 years+ - NCT07609914RecruitingPhase 4
Safety study of an extra dose of rimegepant for migraine
This study tests whether taking an additional dose of rimegepant (a migraine medicine you may already use) is safe and helpful for adults with migraine. Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist—a type of medicine that blocks a protein involved in migraine pain.
Austin, TexasAges 18 years+ - NCT07645924RecruitingPhase 3
Testing a New Migraine Treatment: Elismetrep
This study tests whether a new drug called elismetrep can quickly relieve migraine headaches when taken during an attack. If you have frequent moderate-to-severe migraines, this trial may help you find relief and contribute to better migraine treatments.
Austin, TexasAges 18–75 - NCT04743141RecruitingPhase 3
Long-term migraine medicine study for kids with migraine attacks
This Phase 3 study checks the long-term safety of rimegepant, a migraine treatment, in children and teens. You might join if your child has had migraine for at least 6 months and still gets a certain number of moderate-to-severe migraine attacks.
Austin, TexasAges 6–17 - NCT04649242RecruitingPhase 3
Migraine pain relief study for kids and teens
This trial studies a medicine for stopping a migraine attack in children and teens. It may help families understand which treatment works best during acute (during-attack) migraine pain.
Austin, TexasAges 6–17 - NCT06995729RecruitingPhase 1
Testing zavegepant nasal spray in children with migraines
This trial tests whether the medicine zavegepant (given as a nasal spray) is safe and works well for children aged 6 to 11 who have a history of migraines. If your child gets migraines, this study may help find a new treatment option.
Dallas, TexasAges 6–11 - NCT05127954Enrolling by invitationPhase 3
Long-term migraine tablet study for kids and teens ages 6–17
This study follows kids and teens who already took part in an earlier migraine medication study to check long-term safety and comfort with oral ubrogepant tablets. It may help families understand whether this migraine tablet is safe to keep using over time.
Austin, TexasAges 6–17 - NCT05125302RecruitingPhase 3
Ubrogepant for acute migraine relief in kids and teens
This study tests how safe ubrogepant is and whether it helps treat an individual migraine attack in children and teens. It focuses on measuring side effects and whether headaches improve 2 hours after taking the study medicine.
Austin, TexasAges 6–17 - NCT05049057RecruitingPhase 2
Testing a nerve-blocking shot for recent mild TBI
This Phase 2 study tests a medication that blocks a pain signal (a CGRP receptor antibody) in people who recently had a mild traumatic brain injury (mTBI) and are also dealing with post-traumatic headache (PTH). The goal is to see if it can reduce symptoms and improve recovery after the injury.
El Paso, TexasAges 18–50
Acute Treatment of Migraine trials by city in Texas
Where these studies are running in Texas
Institutions with a site for the recruiting acute treatment of migraine studies listed above.
- AIM Trials, LLC · 6 studies
- Cedar Health Research · 5 studies
- ClinPoint Trials · 4 studies
- DM Clinical Research · 4 studies
- FutureSearch Trials of Dallas · 4 studies
- BioBehavioral Research of Austin · 3 studies
- FutureSearch Trials of Neurology · 3 studies
- 3A Research · 2 studies
What taking part in a acute treatment of migraine study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Common questions
- Are there acute treatment of migraine clinical trials in Texas?
- Yes. We're currently tracking 9 recruiting acute treatment of migraine studies with a site in Texas, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a acute treatment of migraine study in Texas?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Texas to take part?
- Not necessarily. These studies have a site in Texas, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a acute treatment of migraine trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New acute treatment of migraine studies open in Texas regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.